Project IMPACT Immunizations (IMProving America's Communities Together)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1080 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration

NCT03372967

Influenza

COMPLETED

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

NCT03734237

Influenza Influenza-like Illness Influenza Vaccines

ACTIVE_NOT_RECRUITING PHASE4

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM

NCT01868334

Adult Influenza Vaccinations Adult PPSV Vaccinations Adult Tdap/Td Vaccinations

COMPLETED NA

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

NCT00316628

Influenza

COMPLETED PHASE2

Age and Response to Flu Vaccines

NCT03328325

Influenza Influenza Immunisation

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Receiving Influenza Vaccine

Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met.

Vaccine administration by a pharmacist

Intervention Type BIOLOGICAL

Administration, number and types, of vaccine(s) by a pharmacist

Unmet vaccination needs identified and met

Intervention Type BEHAVIORAL

Identification of unmet vaccination needs and having those needs met

Vaccination forecast review and patient education

Intervention Type BEHAVIORAL

Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vaccine administration by a pharmacist

Administration, number and types, of vaccine(s) by a pharmacist

Intervention Type BIOLOGICAL

Unmet vaccination needs identified and met

Identification of unmet vaccination needs and having those needs met

Intervention Type BEHAVIORAL

Vaccination forecast review and patient education

Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.